FTII · Futuretech II Acquisition Corp. - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - | - | - | - | - |
| R&D | - | - | - | - | - | - | - | - | - | - |
| SG&A | $58.7K | $373.8K | - | $287.1K | $204.9K | $230.9K | - | $249.3K | $260.4K | $141.1K |
| Total Operating Expenses | $138.7K | $453.8K | - | $367.1K | $284.9K | $310.9K | - | $329.3K | $221.6K | $93.3K |
| D&A | - | - | - | - | - | - | - | - | - | - |
| Operating Income | ($66.3K) | ($254.0K) | - | ($79.5K) | ($1.8K) | $225.4K | - | $392.0K | ($126.1K) | ($71.5K) |
| Interest Expense | - | $100.0K | - | - | - | $100.0K | - | - | - | $100.0K |
| Income Tax | $14.4K | $35.7K | - | $43.6K | $42.6K | $95.8K | - | $242.0K | $291.6K | $260.1K |
| Net Income | ($80.6K) | ($289.7K) | - | ($123.1K) | ($44.5K) | $129.6K | - | $661.2K | $836.4K | $807.3K |
| EPS - Basic | - | - | - | - | - | - | - | - | - | - |
| EPS - Diluted | - | - | - | - | - | - | - | - | - | - |
Balance Sheet
| Line item | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $160.7K | $130.6K | $56.8K | $1.9K | $476 | $413 | $17.6K | $5.5K | $48.8K | $150.3K |
| Accounts Receivable | - | - | - | - | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - | - | - | - | - |
| Accounts Payable | - | - | - | - | - | - | - | - | - | - |
| Current Assets | $1.45M | $2.05M | $1.67M | $1.56M | $795.4K | $754.8K | $938.5K | $710.7K | $687.6K | $423.9K |
| Total Assets | $10.58M | $11.07M | $28.12M | $28.50M | $27.46M | $26.98M | $62.78M | $61.36M | $124.21M | $121.84M |
| Current Liabilities | $6.93M | $7.34M | $24.44M | $6.20M | $2.63M | $2.57M | $2.12M | $4.59M | $3.88M | $2.34M |
| Long-term Debt | - | - | - | - | - | - | - | - | - | - |
| Total Liabilities | $10.38M | $10.79M | $27.89M | $9.65M | $6.08M | $6.02M | $5.57M | $8.04M | $7.33M | $5.79M |
| Stockholders' Equity | ($9.58M) | ($9.37M) | ($8.85M) | ($7.76M) | ($3.83M) | ($3.90M) | ($3.33M) | ($6.26M) | ($4.84M) | ($4.55M) |
| Retained Earnings | ($9.58M) | ($9.37M) | ($8.86M) | ($7.76M) | ($3.83M) | ($3.90M) | ($3.33M) | ($6.26M) | ($4.84M) | ($4.55M) |
Cash Flow
| Line item | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | - | ($453.2K) | - | - | - | ($282.1K) | - | - | - | ($112.5K) |
| Investing Cash Flow | - | $17.63M | - | - | - | $36.27M | - | - | - | ($1.15M) |
| Financing Cash Flow | - | ($17.10M) | - | - | - | ($36.01M) | - | - | - | $1.15M |
| CapEx | - | - | - | - | - | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | - | - | - | - | - | - |
Ratios
| Metric | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | - | - | - | - | - | - | - | - | - | - |
| Operating margin | - | - | - | - | - | - | - | - | - | - |
| EBITDA margin | - | - | - | - | - | - | - | - | - | - |
| Net margin | - | - | - | - | - | - | - | - | - | - |
| Free cash flow margin | - | - | - | - | - | - | - | - | - | - |
| FCF / Net income | - | - | - | - | - | - | - | - | - | - |
| R&D / Revenue | - | - | - | - | - | - | - | - | - | - |
| SG&A / Revenue | - | - | - | - | - | - | - | - | - | - |
| Effective tax rate | - | - | - | - | - | 42.5% | - | 26.8% | 25.8% | 24.4% |
| Return on assets | -0.8% | -2.6% | - | -0.4% | -0.2% | 0.5% | - | 1.1% | 0.7% | 0.7% |
| Return on equity | 0.8% | 3.1% | - | 1.6% | 1.2% | -3.3% | - | -10.6% | -17.3% | -17.7% |
| Return on invested capital | - | - | - | - | - | - | - | - | - | - |
| Liquidity | ||||||||||
| Current ratio | 0.21 | 0.28 | 0.07 | 0.25 | 0.30 | 0.29 | 0.44 | 0.15 | 0.18 | 0.18 |
| Quick ratio | 0.21 | 0.28 | 0.07 | 0.25 | 0.30 | 0.29 | 0.44 | 0.15 | 0.18 | 0.18 |
| Cash ratio | 0.02 | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.01 | 0.06 |
| Leverage | ||||||||||
| Debt / Equity | - | - | - | - | - | - | - | - | - | - |
| Debt / Assets | - | - | - | - | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest coverage | - | -2.5x | - | - | - | 2.3x | - | - | - | -0.7x |
| Equity multiplier | -1.10 | -1.18 | -3.18 | -3.67 | -7.17 | -6.92 | -18.87 | -9.80 | -25.66 | -26.77 |
| Liabilities / Assets | 0.98 | 0.97 | 0.99 | 0.34 | 0.22 | 0.22 | 0.09 | 0.13 | 0.06 | 0.05 |
| Efficiency | ||||||||||
| Asset turnover | - | - | - | - | - | - | - | - | - | - |
| Inventory turnover | - | - | - | - | - | - | - | - | - | - |
| Days sales outstanding | - | - | - | - | - | - | - | - | - | - |
| Days inventory outstanding | - | - | - | - | - | - | - | - | - | - |
| Days payable outstanding | - | - | - | - | - | - | - | - | - | - |
| Cash conversion cycle | - | - | - | - | - | - | - | - | - | - |
| Valuation | ||||||||||
| P / E | - | - | - | - | - | - | - | - | - | - |
| P / B | - | - | - | - | - | - | - | - | - | - |
| P / S | - | - | - | - | - | - | - | - | - | - |
| EV / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Growth | ||||||||||
| Revenue growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| Revenue CAGR (3y) | - | - | - | - | - | - | - | - | - | - |
| Revenue CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Gross profit growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| Operating income growth (YoY) | -3560.7% | - | - | - | 98.6% | - | - | - | 43.1% | 23.4% |
| Net income growth (YoY) | -81.4% | - | - | - | - | -83.9% | - | 68.7% | - | - |
| EPS growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| EPS CAGR (3y) | - | - | - | - | - | - | - | - | - | - |
| EPS CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| FCF growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | -150.4% | -140.2% | -166.2% | -24.0% | 20.9% | 14.3% | -3.0% | -102.3% | -63.5% | -60.5% |
Peer comparison
Same SIC group: Biological Products, (No Diagnostic Substances)
Comparing FutureTech II Acquisition Corp. against the 5 most active filers in the same SIC group.